Orthofix Medical Inc. Reports Q2 2026 Results; Files 8-K

What Happened
Orthofix Medical Inc. announced its financial results for the quarter ended June 30, 2026 via a press release dated August 5, 2026 and filed those results on Form 8-K (Item 2.02). The company also furnished a corporate investor relations presentation (Item 7.01) that it expects to use, in whole or in part and possibly with modifications, in presentations to investors and analysts during the fiscal year ending December 31, 2026. The 8-K was signed by Julie Andrews, Chief Financial Officer, on August 5, 2026.

Key Details

• Press release announcing Q2 2026 quarterly results filed as Exhibit 99.1 (dated August 5, 2026).
• Corporate investor relations presentation furnished as Exhibit 99.2 (dated August 5, 2026); may be used and modified in investor/analyst presentations in fiscal 2026.
• Filing covers results for the quarter ended June 30, 2026 (Item 2.02 — Results of Operations and Financial Condition).
• Form 8-K signed by Julie Andrews, CFO, on August 5, 2026; Interactive XBRL cover page included as Exhibit 104.

Why It Matters
This 8-K is the company’s formal disclosure of its Q2 2026 earnings and provides the investor presentation management will use to communicate performance and outlook. Retail investors should review the attached press release and presentation (Exhibits 99.1 and 99.2) for the actual revenue, earnings, and any commentary on guidance or business trends, as those details drive short-term market reaction and inform longer-term investment decisions.